Search

Your search keyword '"Lindeman, Neal"' showing total 1,029 results

Search Constraints

Start Over You searched for: Author "Lindeman, Neal" Remove constraint Author: "Lindeman, Neal"
1,029 results on '"Lindeman, Neal"'

Search Results

152. Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program

153. Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study

154. Updated biomarker results from a phase 1/2 study of olaparib and radium-223 in men with metastatic castration-resistant prostate cancer (mCRPC) with bone metastases (COMRADE).

155. MatchMiner: An open source platform for cancer precision medicine

156. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine

157. Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study

158. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva

159. Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

161. An optimized protocol for evaluating pathogenicity of VHL germline variants in patients suspected with von Hippel-Lindau syndrome: Using somatic genome to inform the role of germline variants

170. Identification of a melanoma susceptibility locus and somatic mutation in TET2

171. EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

173. Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients

174. Twists and turns from “tumor in tumor” profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis

175. Identification and management of pathogenic mutations in BRCA1, BRCA2, and PALB2 in a tumor-only genomic testing program.

177. LKB1 modulates lung cancer differentiation and metastasis

178. Twists and turns from 'tumor in tumor' profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis.

179. A Window Into Clinical Next-Generation Sequencing-Based Oncology Testing Practices

180. Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer

181. Reporting Results of Molecular Tests: A Retrospective Examination of BRAF Mutation Reporting

183. Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy

184. Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing

186. Fatty acid synthesis is required for breast cancer brain metastasis

187. A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study

188. Genomic Characterization of de novo Metastatic Breast Cancer

189. Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium

194. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

Catalog

Books, media, physical & digital resources